UK Parliament / Open data

Dangerous Drugs

Proceeding contribution from Chris Philp (Conservative) in the House of Commons on Tuesday, 12 September 2023. It occurred during Debates on delegated legislation on Dangerous Drugs.

We have conducted further engagement and consultation with the ACMD and others in industry to understand the implications of this move. I am jumping ahead a little, but we intend to table a further statutory instrument that will take effect alongside this one, which will make it clear that the sale and use of nitrous oxide for legitimate purposes will not be criminalised in any way—it will continue to be permitted. The definition of legitimate use will be very broadly drawn in that SI, because nitrous oxide is used for a wide range of medical research and commercial purposes, and we are not going to try to comprehensively list those purposes. A wide-based exemption for legitimate use will be put in place to make sure that we do not unintentionally stymie either medical research or commercial use of this drug.

It is worth saying that the use of nitrous oxide is quite widespread. Among those aged 16 to 24—

Type
Proceeding contribution
Reference
737 c849 
Session
2022-23
Chamber / Committee
House of Commons chamber
Back to top